The Valley Desk

Clinical trial reportAmerican journal of hematologyPublished

Fixed-Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
American journal of hematology
Published
Subject terms
Humans; Lymphoma, Follicular; Recurrence; Injections, Subcutaneous; Follow-Up Studies; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Male; Antibodies, Monoclonal, Humanized
PubMed ID
41862428
PubMed Central ID
PMC13055116
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal